Novavax and EC finalized advance purchase agreement for up to 200 million doses of COVID-19 vaccine
On Aug. 4, 2021, Novavax announced that it had reached an agreement with the European Commission (EC) for…
-
-
Bio-Techne’s RNAscope aids in tissue diagnosis of COVID-19 in cases with no previous SARS-CoV-2 testing
On Aug. 4, 2021, Bio-Techne announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC)…
-
NEJM published positive phase 3 trial results for REGEN-COV to prevent SARS-CoV-2 infection
On Aug. 4, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) had published positive detailed…
-
INOVIO dosed first participant in phase 2 trial for its DNA vaccine against MERS, a Coronavirus Disease
On Aug. 4, 2021, Inovio Pharma announced that the company had dosed the first Phase 2 trial subject…
-
Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in India
On Aug. 3, 2021, Illumina announced it had donated US $1 million in sequencing capabilities to the Molecular…
-
Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
On Aug. 3, 2021, Eli Lilly and Incyte announced results from an additional cohort of 101 adult patients…
-
CytoDyn received clearance from Brazil’s FDA (ANVISA) to commence pivotal phase 3 trial in critically ill COVID-19 patients
On Aug. 3, 2021, CytoDyn announced that Brazil’s regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) has approved…
-
FDA cleared Vaxart’s IND application for S-only oral tablet COVID-19 vaccine candidate
On Aug. 2, 2021, Vaxart announced that the U.S. Food and Drug Administration has cleared Vaxart’s Investigational New…
-
MPP, WHO, AFRIGEN, BIOVAC, SAMRC and Africa CDC announced LOI for tech transfer hub in South Africa
On Jul. 30, 2021, the Medicines Patent Pool and the World Health Organization, Afrigen Biologics, the Biologicals and…
-
FDA expanded authorized use of REGEN-CO (casirivimab and imdevimab)
On Jul. 30, 2021, Regeneron announced that the U.S. Food and Drug Administration (FDA) had updated the Emergency…
-
FDA broadened existing EUA of Lilly and Incyte’s baricitinib in patients hospitalized with COVID-19
On Jul. 29, 2021, Incyte announced the U.S. Food and Drug Administration (FDA) had broadened the Emergency Use…
-
Biotechnology | FDA | Imaging | Therapeutics
FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
On Jul. 29, 2021, BOTOX(R) Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA)…
-
Vaxart reported boosting immune responses in subjects previously vaccinated by a Vaxart vaccine
On Jul. 29, 2021, Vaxart announced that it has shown for the first time in clinical trials that…
-
SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African Republic
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants
On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…
-
Oxford vaccine reached one billion doses released
On Jul. 29, 2021, the University of Oxford’s and AstraZeneca announced that one billion doses of the ChAdOx1…
-
National Science Foundation partnerships expand National AI Research Institutes to 40 states
On Jul. 29, 2021, the National Science Foundation announced the establishment of 11 new NSF National Artificial Intelligence…
-
Emergent BioSolutions resumed manufacturing COVID-19 vaccine at Bayview facility
On Jul. 29, 2021, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had begun allowing…
-
Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrated improved immune response and protection in preclinical study
On Jul. 28, 2021, GlaxoSmithKline and Vir Biotechnology announced they had signed a Joint Procurement Agreement with the…
-
Oragenics entered into licensing agreement with the NRC of Canada, to pursue next-generation SARS-CoV-2 vaccines
On Jul. 27, 2021, Oragenics announced it has entered into a licensing agreement with the National Research Council…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | FDA | Infectious Disease | NIH | Non-Profit Research | Vaccine
The COVID-19 Vaccine
The COVID-19 Cartoon illustrates the further politicalization of the U.S. Healthcare System. The choice between getting a vaccine,…
-
Department of Veterans Affairs mandated COVID-19 vaccines among employees, including facilities staff
On Jul. 26, 2021, the Department of Veterans Affairs (VA) announced that it had mandated COVID-19 vaccines for…
-
Phase I trial began of new vaccine against the Plague
On Jul. 26, 2021, researchers at the University of Oxford launched a Phase 1 trial to test a…
-
Biotechnology | Clinical Research | COVID-19 | NIH | Vaccine
Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19
On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…
-
American Medical Association announced support of COVID-19 vaccine mandates for health care workers
On Jul. 26, 2021, the American Medical Association (AMA) call for all health care and long-term care employers…
-
American Nurses Association supported mandated COVID-19 vaccinations for nurses and all health care professionals
On Jul. 26, 2021, the American Nurses Association (ANA), representing the interests of the nationﾒs 4.2 million registered…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Infectious Disease | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 vacation Destinations
Planning a Summer vacation? Where to go? How about going to one of those large events with tens…
-
Pfizer and BioNTech to supply U.S. Government with additional 200 million doses of COVID-19 vaccine
On Jul. 23, 2021, Pfizer and BioNTech announced that the U.S. government has purchased an additional 200 million…
-
Twist Bioscience began shipping synthetic RNA positive controls for Delta (B.1.617.2) SARS-CoV-2 variant
On Jul. 22, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
-
Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster
On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…
